Risperidone (Risperdal): increased rate of cerebrovascular events in dementia trials.
- 26 November 2002
- journal article
- Vol. 167 (11) , 1269-70
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Advances in the pharmacotherapy of Alzheimer's disease.2002
- Antipsychotic Metabolic Effects: Weight Gain, Diabetes Mellitus, and Lipid AbnormalitiesThe Canadian Journal of Psychiatry, 2001
- Underlying mechanisms of psychosis and aggression in patients with Alzheimer's disease.2001
- Risperidone for the treatment of behavioral and psychological symptoms of dementia.2001
- Treating behavioural and psychological signs in Alzheimer's diseaseBMJ, 1999
- Caring for elderly people at home: the consequences to caregivers1997
- Risperidone for schizophreniaBMJ, 1994
- Canadian study of health and aging: study methods and prevalence of dementia.1994